MacBeath Gavin
SEC CIK 1738082 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | CSO | 49.7K | $31.1K | — | 1 | 2021-09-20 | 2021-09-20 |
Most active insiders at TCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 10% | $145.6K | — |
MacBeath Gavin made no open-market trades at TCRX in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-22 | 2021-09-20+ | TCRX | TScan Therapeutics, Inc. | MacBeath Gavin | CSO | P - Purchase | $6.22 | +5,000 | 49.7K | +11% | +$31.1K |
Purchase Sale Sale after option exercise All abbreviations